topotecan has been researched along with beta-escin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, HZ; Feng, SY; Li, RM; Lin, S; Luo, XJ; Qian, CM; Sun, L; Yu, BY; Yu, XW; Yuan, ST; Zhang, LY; Zhao, RP | 1 |
Chen, X; Du, H; Hou, X; Li, H; Lin, S; Liu, Y; Lu, L; Sun, L; Yu, X; Yuan, S; Zhan, M | 1 |
Du, HZ; Gao, YS; Li, RM; Luo, XJ; Qian, CM; Sun, L; Wang, JS; Wei, D; Yu, BY; Yu, XW; Yuan, ST | 1 |
3 other study(ies) available for topotecan and beta-escin
Article | Year |
---|---|
Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Synergism; Endocytosis; ErbB Receptors; Female; HEK293 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nonmuscle Myosin Type IIA; Saponins; Signal Transduction; Stomach Neoplasms; Topotecan; Xenograft Model Antitumor Assays | 2016 |
DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo.
Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Saponins; Stomach Neoplasms; Topotecan | 2018 |
Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA/EGFR/HK II axis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Drug Synergism; Endocytosis; ErbB Receptors; Female; Glycolysis; Hexokinase; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Nonmuscle Myosin Type IIA; RNA, Small Interfering; Saponins; Stomach Neoplasms; Topotecan; Xenograft Model Antitumor Assays | 2019 |